First generic Trileptal products get FDA nod

October 11, 2007

First oxcarbazepine receives approval for seizure disorders

Roxane Laboratories, Glenmark Pharmaceuticals, and Sun Pharmaceuticals have all received FDA approval for their generic versions of Trileptal (oxcarbazepine). The drug is indicated for use alone or in combination with other medications for the treatment of partial seizures in adults and children four years of age and older. Oxcarbazepine will be available in three strengths: 150 mg-, 300-mg, and 600-mg tablets.

Click here to see more articles from Drug Topics Daily News.

To go to the Drug Topics homepage, click here.